Lantern Pharma (LTRN) Q1 2025 Earnings

27MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.56
-0.51
-0.47
-0.42

Details

Expected EPS
-0.51
Actual EPS
-0.54
Surprise EPS
-0.03
Surprise Percent
+5.88%

Description

Lantern Pharma (LTRN) has reported earnings of -0.54 per share for Q1 2025.

0 Comments

Share your thoughts